A detailed break-out of the company’s first quarter financial report shows its line of orthopedic products contributed approximately $39.6 million, indicating a 34 percent increase from the first quarter of last year. The increase stems from moderate orthopedic market growth, customer inventory builds and customer product launches.
Read the company news release about Greatbatch’s first quarter financial results.
Related Articles on Financial Results:
Biomet Announces 4Q FY 2010 Financial Results
NuVasive Reports 4Q Revenue of $129.3M, 20.9% Increase
Centinel Spine Reports 47% Increase in Q1 Sales
